Literature DB >> 3581899

Epidemiology and control of Lassa fever.

J B McCormick.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3581899     DOI： 10.1007/978-3-642-71726-0_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  39 in total

1.  Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Authors:  Juan C Zapata; Marco Goicochea; Yuka Nadai; Lindsay M Eyzaguirre; Jean K Carr; Luke J Tallon; Lisa Sadzewicz; Garry Myers; Claire M Fraser; Qi Su; Mahmoud Djavani; Igor S Lukashevich; Maria S Salvato
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

3.  Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Authors:  Helena Müller; Sarah Katharina Fehling; Jens Dorna; Richard A Urbanowicz; Lisa Oestereich; Yvonne Krebs; Larissa Kolesnikova; Martin Schauflinger; Verena Krähling; N'Faly Magassouba; Elisabeth Fichet-Calvet; Jonathan K Ball; Andreas Kaufmann; Stefan Bauer; Stephan Becker; Veronika von Messling; Thomas Strecker
Journal:  NPJ Vaccines       Date:  2020-08-04       Impact factor: 7.344

4.  Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene.

Authors:  S P Fisher-Hoch; J B McCormick; D Auperin; B G Brown; M Castor; G Perez; S Ruo; A Conaty; L Brammer; S Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.

Authors:  F T Hufert; W Lüdke; H Schmitz
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Genetic diversity among Lassa virus strains.

Authors:  M D Bowen; P E Rollin; T G Ksiazek; H L Hustad; D G Bausch; A H Demby; M D Bajani; C J Peters; S T Nichol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Authors:  Luis M Branco; Jessica N Grove; Lina M Moses; Augustine Goba; Mohammed Fullah; Mambu Momoh; Randal J Schoepp; Daniel G Bausch; Robert F Garry
Journal:  Virol J       Date:  2010-11-09       Impact factor: 4.099

8.  Molecular determinants of Pichinde virus infection of guinea pigs--a small animal model system for arenaviral hemorrhagic fevers.

Authors:  Yuying Liang; Shuiyun Lan; Hinh Ly
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

9.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

10.  Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms.

Authors:  Luis M Branco; Robert F Garry
Journal:  Virol J       Date:  2009-09-24       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.